Connect with us

Technology

iRobot Reports Third-Quarter 2024 Financial Results

Published

on

Continues to Make Progress on “iRobot Elevate” Strategy

Revises Full-year 2024 Outlook

BEDFORD, Mass., Nov. 6, 2024 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the third quarter ended September 28, 2024.

“We continue to make progress on our turnaround strategy,” said Gary Cohen, iRobot’s CEO. “In the third quarter, we expanded our non-GAAP gross margin by 590 basis points year over year and improved our use of operating cash. However, our overall results did not meet the expectations we set in August, as persistent market segment and competitive headwinds impacted our sell-through performance. Although we now expect it will take more time to stabilize our revenue trend, we are on track to exceed our operating expense targets for the year, while at the same time continuing to invest in areas that are expected to drive growth.

“Our ongoing restructuring has fundamentally changed the way we innovate, develop and build our robots, which is central to improving our performance and generating long-term shareholder value. With the benefit of lower operating costs, we expect to enhance margins and improve profitability in 2025.

“As we move forward in this new chapter in iRobot’s history, one thing is abundantly clear: we have a powerful brand that will serve as the foundation for the turnaround of this Company. That brand power is at the heart of our turnaround strategy, iRobot Elevate. In executing that strategy, we are focused on providing our iconic brand with an improved platform to drive long-term profitable growth.”

Third-Quarter 2024 Financial Results (in millions, except per share amounts and percentages)

Q3 2024

Q3 2023

Revenue

$193.4

$186.2

GAAP Gross Margin

32.2 %

25.8 %

Non-GAAP Gross Margin

32.4 %

26.5 %

GAAP Operating Expenses

$55.1

$107.5

Non-GAAP Operating Expenses

$47.7

$90.1

GAAP Operating Income (Loss)

$7.3

($59.5)

Non-GAAP Operating Income (Loss)

$15.1

($40.6)

GAAP Net Loss Per Share

($0.21)

($2.86)

Non-GAAP Net Income (Loss) Per Share*

$0.03

($2.82)

*Beginning in the fourth quarter of fiscal 2023, the Company updated its calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics are presented in accordance with this updated methodology. As a result, the third quarter ended September 30, 2023 differs from those previously presented by the amount of IP litigation expense, net recorded in such period.

Additional Financial Highlights 

The Company increased non-GAAP gross margin in the third quarter by 590 basis points year over year as a result of its restructuring and iRobot Elevate initiatives.As of September 28, 2024, the Company’s cash and cash equivalents totaled $99.4 million, compared with $108.5 million as of the end of the second quarter of 2024. The Company also had an additional $41.1 million restricted cash set aside for future repayment of its term loan, subject to limited rights for inventory purchases, of which $40.0 million was drawn down at the close of the third quarter and received in the fourth quarter.As of September 28, 2024, the Company’s inventory totaled $149.2 million, compared with $244.5 million as of the end of the third quarter of 2023.During the third quarter, the Company sold 0.2 million shares under its at-the-market (ATM) offering program for total net proceeds of $1.4 million. At quarter end, the Company had $79.6 million remaining under its $100 million ATM offering program.As of September 28, 2024, iRobot had reduced its total headcount by 41% since year-end 2023.In the third quarter of 2024, revenue increased 23% in the U.S., declined 20% in Japan, and declined 11% in EMEA over the prior-year period. Excluding the unfavorable foreign currency impact, Japan revenue decreased 15% over the prior-year period.Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 79% of total robot sales in the third quarter of 2024, compared with 80% in the same period last year.

Marketing Highlights 

iRobot introduced the 2-in-1 Roomba Combo 2 Essential robot globally and Roomba Vac 2 Essential robot in North America. These robots are the first in the Company’s affordable Essential series that automatically empty their dustbins into the AutoEmpty dock after cleaning. The robots also provide twice the cleaning power of the original Essential series, include an enhanced bumper design to more seamlessly navigate floor space, and have the ability to recharge and resume during cleaning missions.In August, iRobot launched the Roomba Combo 10 Max in Japan, earning positive coverage in media outlets including Nikkei, NHK and Gizmodo.iRobot Roomba Combo Essential received the PCMag Editor’s Choice designation.iRobot products received favorable media coverage across the globe, including from CBS News, Engadget, The Verge, Tom’s Guide, ZDNet, The Ambient, and Europa Press.Roomba was a featured product in Amazon’s Prime Big Deal Days event in October. iRobot’s products received Prime Big Deal Day related media coverage in outlets including Good Morning America, NBC Select, The Sun, Frandroid and El Confidencial.

Fourth-Quarter and Full-Year 2024 Outlook

iRobot is providing GAAP and non-GAAP financial expectations for the fourth quarter ending December 28, 2024 and updating the full-year 2024 outlook it provided on August 7, 2024. A detailed reconciliation between the Company’s GAAP and non-GAAP expectations is included in the financial tables that appear at the end of this press release.

Fourth Quarter 2024:

Metric

GAAP

Adjustments

Non-GAAP

Revenue

$175 – $200 million

$175 – $200 million

Gross Margin

24% – 27%

~0%

24% – 27%

Operating Loss

($43) – ($34) million

~$12 million

($31) – ($22) million

Net Loss Per Share

($1.88) – ($1.58)

~$0.38

($1.50) – ($1.20)

Fiscal Year 2024:

Metric

GAAP

Adjustments

Non-GAAP

Revenue

$685 – $710 million

$685 – $710 million

Gross Margin

25% – 26%

~0%

25% – 26%

Operating Loss

($84) – ($75) million

~($20) million

($104) – ($95) million

Net Loss Per Share

($4.27) – ($3.96)

~($0.64)

($4.91) – ($4.60)

Third-Quarter 2024 Results Conference Call

On November 6, the Company will host a live conference call and webcast to review its financial results and discuss its outlook. The conference call details are as follows:

Date: Wednesday, November 6, 2024
Time: 8:30 a.m. ET
Call-In Number: 800-274-8461 (Alternate: 203-518-9814)
Conference ID: IRBTQ324

A live webcast of the conference call will be accessible on the event section of the Company’s website at https://investor.irobot.com/financial-information/quarterly-results. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event.

About iRobot Corp.
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 50 million robots worldwide. iRobot’s product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com

Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company’s expectations regarding future financial performance, including with respect to fourth quarter and fiscal year 2024 revenue, gross margin, operating (loss) income and net (loss) income per share, as well as fiscal year 2025 operating costs, margins and profitability; executing on the Company’s iRobot Elevate strategy; stabilization of revenue trends; and the Company’s business plans and strategies and the anticipated impact thereof. These forward-looking statements are based on the Company’s current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company’s ability to obtain capital when desired on favorable terms, if at all; (ii) the Company’s ability to realize the benefits of its operational restructuring; (iii) the impact of the COVID-19 pandemic and various global conflicts on the Company’s business and general economic conditions; (iv) the Company’s ability to implement its business strategy; (v) the risk that disruptions from the operational restructuring will harm the Company’s business, including current plans and operations; (vi) the ability of the Company to retain and hire key personnel, including successfully navigating its leadership transition; (vii) legislative, regulatory and economic developments affecting the Company’s business; (viii) general economic and market developments and conditions; (ix) the evolving legal, regulatory and tax regimes under which the Company operates; (x) potential business uncertainty, including changes to existing business relationships that could affect the Company’s financial performance; (xi) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xii) current supply chain challenges including the Red Sea conflict; (xiii) the financial strength of our customers and retailers; (xiv) the impact of tariffs on goods imported into the United States; and (xv) competition, as well as the Company’s response to any of the aforementioned factors. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

 

iRobot Corporation

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

Revenue

$               193,435

$               186,176

$               509,811

$               583,036

Cost of revenue:

Cost of product revenue

131,058

137,888

383,865

443,932

Amortization of acquired intangible assets

292

864

Total cost of revenue

131,058

138,180

383,865

444,796

Gross profit

62,377

47,996

125,946

138,240

Operating expenses:

Research and development

19,630

37,336

76,739

116,576

Selling and marketing

29,270

41,558

98,966

139,630

General and administrative

3,232

28,270

(33,552)

85,116

Restructuring and other

1,922

152

24,298

8,236

Amortization of acquired intangible assets

1,066

174

1,405

529

Total operating expenses

55,120

107,490

167,856

350,087

Operating income (loss)

7,257

(59,494)

(41,910)

(211,847)

Other expense, net

(12,548)

(19,113)

(24,583)

(24,217)

Loss before income taxes

(5,291)

(78,607)

(66,493)

(236,064)

Income tax expense

1,080

598

1,917

5,053

Net loss

$                  (6,371)

$                (79,205)

$                (68,410)

$              (241,117)

Net loss per share:

Basic

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Diluted

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Number of shares used in per share calculations:

Basic

30,348

27,738

29,276

27,608

Diluted

30,348

27,738

29,276

27,608

Stock-based compensation included in above figures:

Cost of revenue

$                      387

$                      838

$                   1,486

$                   2,226

Research and development

1,296

3,355

4,994

8,737

Selling and marketing

903

1,384

3,403

4,221

General and administrative

2,894

3,798

8,054

10,696

Total

$                   5,480

$                   9,375

$                 17,937

$                 25,880

 

 iRobot Corporation

 Condensed Consolidated Balance Sheets

 (unaudited, in thousands)

September 28, 2024

December 30, 2023

 Assets

 Cash and cash equivalents

$                       99,447

$                   185,121

 Restricted cash

41,082

 Accounts receivable, net

101,326

79,387

 Inventory

149,156

152,469

 Other current assets

32,774

48,513

Total current assets

423,785

465,490

 Property and equipment, net

25,405

40,395

 Operating lease right-of-use assets

15,137

19,642

 Deferred tax assets

9,093

8,512

 Goodwill

175,928

175,105

 Intangible assets, net

3,635

5,044

 Other assets

16,932

19,510

Total assets

$                     669,915

$                   733,698

 Liabilities and stockholders’ equity

 Accounts payable

$                     195,133

$                   178,318

 Accrued expenses

88,384

97,999

 Deferred revenue and customer advances

9,121

10,830

Total current liabilities

292,638

287,147

 Term loan

186,713

201,501

 Operating lease liabilities

22,892

27,609

 Other long-term liabilities

17,510

20,954

Total long-term liabilities

227,115

250,064

Total liabilities

519,753

537,211

 Stockholders’ equity

150,162

196,487

Total liabilities and stockholders’ equity

$                     669,915

$                   733,698

 

 iRobot Corporation

Consolidated Statements of Cash Flows

 (unaudited, in thousands)

For the nine months ended

September 28, 2024

September 30, 2023

Cash flows from operating activities:

Net loss

$                (68,410)

$              (241,117)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

16,912

21,367

Loss on equity investment

375

3,910

Stock-based compensation

17,937

25,880

Provision for inventory excess and obsolescence

11,800

1,740

Change in fair value of term loan

13,515

5,292

Debt issuance costs expensed under fair value option

529

11,837

Deferred income taxes, net

(651)

4,115

Other

(6,318)

(8,618)

Changes in operating assets and liabilities — (use) source

Accounts receivable

(22,073)

(7,943)

Inventory

(10,539)

32,935

Other assets

15,598

12,544

Accounts payable 

16,674

28,904

Accrued expenses and other liabilities

(15,825)

(4,483)

Net cash used in operating activities

(30,476)

(113,637)

Cash flows from investing activities:

Additions of property and equipment

(118)

(3,132)

Purchase of investments

(56)

(213)

Net cash used in investing activities

(174)

(3,345)

Cash flows from financing activities:

Proceeds from employee stock plans

9

Income tax withholding payment associated with restricted stock vesting

(491)

(1,924)

Proceeds from issuance of common stock, net of issuance costs

19,359

Repayment of term loan

(34,947)

Proceeds from term loan

200,000

Payment of debt issuance costs

(529)

(11,837)

Net cash (used in) provided by financing activities

(16,608)

186,248

Effect of exchange rate changes on cash, cash equivalents and restricted cash

1,251

4,193

Net (decrease) increase in cash, cash equivalents and restricted cash

(46,007)

73,459

Cash, cash equivalents and restricted cash, at beginning of period

187,887

117,949

Cash, cash equivalents and restricted cash, at end of period

$               141,880

$               191,408

Cash, cash equivalents and restricted cash, at end of period:

Cash and cash equivalents

$                 99,447

$               189,649

Restricted cash

41,082

Restricted cash, non-current (included in other assets)

1,351

1,759

Cash, cash equivalents and restricted cash, at end of period

$               141,880

$               191,408

 

 iRobot Corporation

Supplemental Information

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

Revenue by Geography: *

    Domestic

$               105,137

$                 85,781

$               258,398

$               288,725

    International

88,298

100,395

251,413

294,311

Total

$               193,435

$               186,176

$               509,811

$               583,036

Robot Units Shipped *

    Solo and other

287

446

854

1,492

    2-in-1

445

181

908

403

Total

732

627

1,762

1,895

Revenue by Product Category **

    Solo and other

$                        83

$                      126

$                      268

$                      449

    2-in-1

110

60

242

134

Total

$                      193

$                      186

$                      510

$                      583

Average gross selling prices for robot units

$                      313

$                      331

$                      329

$                      354

Headcount

661

1,126

* in thousands

** in millions

Certain numbers may not total due to rounding

 

iRobot Corporation
Explanation of Non-GAAP Measures

In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.

Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.

Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures, including with respect to the iRobot-Amazon Merger. It also includes business combination adjustments including adjustments after the measurement period has ended. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.

Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.

Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.

Debt issuance costs: Debt issuance costs include various incremental fees and commissions paid to third parties in connection with the issuance of debt. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Income tax adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowances based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.

iRobot Corporation

Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

 GAAP Revenue

$               193,435

$               186,176

$               509,811

$               583,036

 GAAP Gross Profit

$                 62,377

$                 47,996

$               125,946

$               138,240

Amortization of acquired intangible assets

292

864

Stock-based compensation

387

838

1,486

2,226

Net merger, acquisition and divestiture expense

288

898

 Non-GAAP Gross Profit

$                 62,764

$                 49,414

$               127,432

$               142,228

 GAAP Gross Margin

32.2 %

25.8 %

24.7 %

23.7 %

 Non-GAAP Gross Margin

32.4 %

26.5 %

25.0 %

24.4 %

 GAAP Operating Expenses

$                 55,120

$               107,490

$               167,856

$               350,087

Amortization of acquired intangible assets

(1,066)

(174)

(1,405)

(529)

Stock-based compensation 

(5,093)

(8,537)

(16,451)

(23,654)

Net merger, acquisition and divestiture income (expense)

656

(8,564)

74,813

(21,991)

Restructuring and other

(1,922)

(152)

(24,298)

(8,236)

 Non-GAAP Operating Expenses*

$                 47,695

$                 90,063

$               200,515

$               295,677

 GAAP Operating Expenses as a % of GAAP Revenue

28.5 %

57.7 %

32.9 %

60.0 %

 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue*

24.7 %

48.4 %

39.3 %

50.7 %

 GAAP Operating Income (Loss)

$                   7,257

$                (59,494)

$                (41,910)

$              (211,847)

Amortization of acquired intangible assets

1,066

466

1,405

1,393

Stock-based compensation

5,480

9,375

17,937

25,880

Net merger, acquisition and divestiture (income) expense

(656)

8,852

(74,813)

22,889

Restructuring and other

1,922

152

24,298

8,236

 Non-GAAP Operating Income (Loss)*

$                 15,069

$                (40,649)

$                (73,083)

$              (153,449)

 GAAP Operating Margin

3.8 %

(32.0) %

(8.2) %

(36.3) %

 Non-GAAP Operating Margin*

7.8 %

(21.8) %

(14.3) %

(26.3) %

iRobot Corporation

Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

 GAAP Income Tax Expense

$                   1,080

$                      598

$                   1,917

$                   5,053

Tax effect of non-GAAP adjustments

650

32,045

1,667

565

Other tax adjustments

(203)

(1,638)

(811)

(4,150)

 Non-GAAP Income Tax Expense

$                   1,527

$                 31,005

$                   2,773

$                   1,468

 GAAP Net Loss

$                  (6,371)

$                (79,205)

$                (68,410)

$              (241,117)

Amortization of acquired intangible assets

1,066

466

1,405

1,393

Stock-based compensation

5,480

9,375

17,937

25,880

Net merger, acquisition and divestiture (income) expense

(656)

8,852

(74,813)

22,889

Restructuring and other

1,922

152

24,298

8,236

Loss on strategic investments

758

375

3,910

Debt issuance costs

52

11,837

529

11,837

Income tax effect

(447)

(30,407)

(856)

3,585

 Non-GAAP Net Income (Loss)*

$                   1,046

$                (78,172)

$                (99,535)

$              (163,387)

 GAAP Net Loss Per Diluted Share

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Amortization of acquired intangible assets

0.03

0.02

0.05

0.05

Stock-based compensation

0.18

0.34

0.61

0.93

Net merger, acquisition and divestiture (income) expense

(0.02)

0.32

(2.55)

0.83

Restructuring and other

0.06

0.83

0.30

Loss on strategic investments

0.03

0.01

0.14

Debt issuance costs

0.43

0.02

0.43

Income tax effect

(0.01)

(1.10)

(0.03)

0.13

 Non-GAAP Net Income (Loss) Per Diluted Share*

$                     0.03

$                    (2.82)

$                    (3.40)

$                    (5.92)

Number of shares used in diluted per share calculation

30,551

27,738

29,276

27,608

Supplemental Information

Days sales outstanding

48

36

GAAP Days in inventory

104

161

Non-GAAP Days in inventory(1)

104

163

* Beginning in the fourth quarter of fiscal 2023, we updated our calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics for each period are presented in accordance with this updated methodology; as a result, the third quarter and the nine months ended September 30, 2023 differ from those previously presented by the amount of IP litigation expense, net recorded in such period.

(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days.

 

 iRobot Corporation

Supplemental Reconciliation of Fourth Quarter and Full Year 2024 GAAP to Non-GAAP Guidance

(unaudited)

Q4-24

FY-24

GAAP Gross Profit

$42 – $54 million

$168 – $179 million

Stock-based compensation

~$0 million

~$2 million

Total adjustments

~$0 million

~$2 million

Non-GAAP Gross Profit

$42 – $54 million

$170 – $181 million

Q4-24

FY-24

GAAP Gross Margin

24% – 27%

25% – 26%

Stock-based compensation

~0%

~0%

Total adjustments

~0%

~0%

Non-GAAP Gross Margin

24% – 27%

25% – 26%

Q4-24

FY-24

GAAP Operating Expenses

$85 – $86 million

$252 – $254 million

Amortization of acquired intangible assets

~($0) million

~($2) million

Stock-based compensation

~($6) million

~($23) million

Net merger, acquisition and divestiture income (expense)

~$75 million

Restructuring and other

~($5) million

~($29) million

Total adjustments

~($11) million

~$22 million

Non-GAAP Operating Expenses

$74 – $75 million

$274 – $276 million

Q4-24

FY-24

GAAP Operating Loss

($43) – ($34) million

($84) – ($75) million

Amortization of acquired intangible assets

~$0 million

~$2 million

Stock-based compensation

~$7 million

~$25 million

Net merger, acquisition and divestiture expense (income)

~($75) million

Restructuring and other

~$5 million

~$29 million

Total adjustments

~$12 million

~($20) million

Non-GAAP Operating Loss

($31) – ($22) million

($104) – ($95) million

Q4-24

FY-24

GAAP Net Loss Per Share

($1.88) – ($1.58)

($4.27) – ($3.96)

Amortization of acquired intangible assets

~$0.01

~$0.05

Stock-based compensation

~$0.22

~$0.83

Net merger, acquisition and divestiture expense (income)

~($2.53)

Restructuring and other

~$0.15

~$0.98

Loss on strategic investments

~$0.01

Debt issuance costs

~$0.02

Income tax effect

~$0

~$0

Total adjustments

~$0.38

~($0.64)

Non-GAAP Net Loss Per Share

($1.50) – ($1.20)

($4.91) – ($4.60)

Number of shares used in per share calculations*

~30.6 million

~29.6 million

* Number of shares does not include any additional issuances under our ATM

Certain numbers may not total due to rounding

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/irobot-reports-third-quarter-2024-financial-results-302297065.html

SOURCE iRobot Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors

Published

on

By

RADNOR, Pa., Nov. 6, 2024 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D., as a director with an initial term expiring at Avantor’s 2025 Annual Meeting of Stockholders. The appointment of Dame Louise as an independent director fills a vacant board seat.

Dame Louise brings a wealth of leadership and industry experience to the Avantor Board. She served as Chief Executive Officer of BTG plc, an international specialist healthcare company, for 15 years and led their transformation through organic growth and acquisitions. The company was acquired by Boston Scientific in 2019. Earlier in her career, she held several leadership positions at Baxter Healthcare, most recently as President of Biopharmaceuticals Europe.

“Dame Louise has a proven track record of success in the life sciences industry, and we are excited to welcome her to the Avantor Board of Directors,” said Jonathan Peacock, Chairman of the Avantor Board. “Her addition further demonstrates Avantor’s commitment to ensuring we have a diverse Board, with the right mix of skillsets and experience to drive innovation across our portfolio, advance our mission, and create long-term shareholder value.”

“It is an honor to join the Avantor Board of Directors, and I look forward to working closely with the board and executive team to further strengthen the company’s position as a leader in the life sciences and advanced technologies industries,” said Dame Louise. “Avantor’s global reach, innovative products, and services uniquely position it to drive advancements at every stage of the scientific journey and deliver differentiated value to its many stakeholders.”

“Dame Louise is an excellent addition to our Board. I welcome her insights and expertise as we continue to execute our strategic plan to drive long-term growth and value creation,” said Michael Stubblefield, Avantor President and Chief Executive Officer.

Dame Louise currently serves as non-executive chair of the Halma plc Board of Directors and has served as a Non-Executive Director on the Boards of Premier Foods plc, Intertek Group plc, Woodford Patient Capital Trust, Atotech Ltd., and Theramex Ltd. She was also a Trustee of The Outward Bound Trust for 10 years and Chair of the 1851 Trust for five years.

Dame Louise is an Honorary Fellow of St John’s College, Cambridge. She holds both a master’s degree in natural sciences and a Ph.D. in material sciences from the University of Cambridge and earned an MBA from The Open University in Milton Keynes, England. She became a Dame Commander of the Order of the British Empire in 2014.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

 

View original content:https://www.prnewswire.com/news-releases/avantor-appoints-dame-louise-makin-dbe-phd-to-its-board-of-directors-302297011.html

SOURCE Avantor and Financial News

Continue Reading

Technology

Phoenix IB Advises Spray Products in Successful $40 Million Refinancing

Published

on

By

PHILADELPHIA, Nov. 6, 2024 /PRNewswire/ — Phoenix IB®, a part of J.S. Held, a leading middle market special situations investment bank and independent licensed broker-dealer under federal and state securities law (CRD#: 132710/SEC#: 8-66628), acted as the exclusive investment banker to its long-term client, Spray Products Corporation, in arranging, structuring, and negotiating a $40 million loan package with Legacy Corporate Lending. 

J.S. Held subsidiary Phoenix IB closes refinancing with Legacy Corporate Lending.

“Phoenix IB is delighted with the credit package we were able to arrange for Spray Products,” noted Michael Jacoby, a Senior Managing Director at Phoenix IB. “Not surprisingly, there was a lot of interest from a variety of lenders, both regulated and non-regulated. The Legacy team spent the time to understand the Company and its business plan, and tailored a solution that fit Spray’s needs and will provide the necessary support for years to come.”

Spray Products is a leading custom contract manufacturer of aerosol and liquid consumer products. Proceeds from the financing will be utilized to refinance the Company’s existing credit facilities and fund additional working capital to finance its continued growth and capital expenditures. Peter Bastian, Executive Vice President of Spray Products LLC, shares, “We could not be more pleased with the closing of our new financing with Legacy Corporate Lending and the guidance we received throughout the transaction from Phoenix IB. The Phoenix team was able to successfully communicate our story, and through our new facility with Legacy, we are confident we have partnered with a firm that shares our values and is excited to support Spray’s next phase of growth.” 

Legacy Corporate Lending LLC, in alliance with Bain Capital Credit, L.P., specializes in providing revolving credit facilities and term loans to businesses across diverse industries. The firm aims to facilitate access to capital for companies seeking alternatives to traditional bank lending or the syndicated lending market.

“We were extremely impressed with the refinancing process that Phoenix IB led for Spray Products,” said Clark Griffith, CEO of Legacy Corporate Lending, LLC. “The professionalism and fairness shown by Steven Warsaw, Michael Jacoby, and the team was refreshing to experience and appreciated in this competitive market. Our process was easy to navigate given the quality of the information, their responsiveness to questions, and the approach they took in understanding the best borrower/lender fit.”

Doug Greer, Spray Products Chief Financial Officer, adds, “Michael Jacoby, Steven Warsaw, and their team spent considerable time to understand the intricacies of our business and worked closely with us to develop a financing structure that meets our needs for the next several years. We believe that we will continue to see the benefits of their collaboration with our business well beyond our engagement.”

Across a broad spectrum of client types, from start-ups in an early stage with exciting growth potential to a mature company amid a corporate turnaround, Phoenix IB capital raising services are designed to provide tailored financing solutions across the capital structure, particularly for clients faced with complex growth or funding situations. “At Phoenix IB, every transaction we close reflects our precision, perseverance, and partnership with our clients,” shares Phoenix IB Managing Director Steven C. Warsaw. Mr. Warsaw continues, “The robust interest in financing Spray Products created a highly competitive process, and we are very pleased to have selected the loan package provided by Legacy, which we feel is best positioned to provide needed flexibility as Spray facilitates its next chapter of growth.”

About Phoenix IB

Phoenix IB is a boutique, special situations-oriented investment bank providing seamless investment banking solutions, including M&A advisory, complex restructurings, and capital placements. Phoenix IB is a US registered broker-dealer and member of FINRA and SIPC.

As a part of J.S. Held, Phoenix works alongside more than 1500 professionals globally and assists clients – corporations, insurers, law firms, governments, and institutional investors.

J.S. Held is a global consulting firm that combines technical, scientific, financial, and strategic expertise to advise clients seeking to realize value and mitigate risk. Our professionals serve as trusted advisors to organizations facing high-stakes events demanding urgent attention, staunch integrity, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.

J.S. Held professionals serve organizations across six continents, including 81% of the Global 200 Law Firms, 70% of the Forbes Top 20 Insurance Companies (85% of the NAIC Top 50 Property & Casualty Insurers), and 65% of the Fortune 100 Companies.

J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held, its affiliates and subsidiaries are not law firms and do not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB, a part of J.S. Held, member FINRA/ SIPC or Ocean Tomo Investment Group, LLC, a part of J.S. Held, member FINRA/ SIPC. All rights reserved.

Media Contact

Kristi L. Stathis, J.S. Held, +1 773 294 4360, Kristi.Stathis@jsheld.com, JSHeld.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/phoenix-ib-advises-spray-products-in-successful-40-million-refinancing-302297143.html

SOURCE Phoenix IB, a part of J.S. Held

Continue Reading

Technology

Grovara’s Safe B2B CPG Global Trading Platform Expands Product Offering Into Eyewear, Will Add 10-Plus Complementary Verticals By End Of 2025

Published

on

By

PHILADELPHIA, Nov. 6, 2024 /PRNewswire/ — Grovara, the safe, all-in-one platform streamlining global trade for the Business-to-Business (B2B) Consumer Packaged Goods (CPG) industry, is expanding the offerings on its online marketplace beyond food and beverage beginning with the rapidly growing eyewear market.

The global eyewear market is projected to grow by more than 18% through 2029, presenting a tremendous growth opportunity via higher margins and increasing online sales. Grovara is now selling Popticals, collapsible sunglasses for active lifestyles featuring Italian craftsmanship and superior lens technology. In the coming weeks there are plans to add additional eyewear brands, which can now tap Grovara’s technology to simplify their typical sales transaction from three weeks to three clicks. 

“The potential for Grovara’s platform is infinite, and expanding into the eyewear vertical is a great step forward as we ramp up and evolve our SaaS technology offering,” says Grovara CEO Peter Groverman. “Whether you’re selling a kombucha or carousel of sunglasses, the transaction process is the same and Grovara’s platform handles the full process.”

Popticals deliver an unequaled combination of quality, performance, and convenience. The brand boasts an innovative nylon-based lens technology, plus a patented micro-rail system that allows its glasses to collapse down for uniquely easy storage.

“We are excited to join Grovara’s growing platform and bring our unique product within the premium sunglasses market to a global audience,” says Gary DiSalvo, Owner and CEO of Popticals. “This partnership allows us to share our commitment to quality and innovation with more people. Additionally, it aligns with Grovara’s mission of making high-quality, complementary products easily accessible to businesses around the world.”

Over the last decade, Grovara has become a leader in the natural food and beverage sector by growing the global profile of some of the most well-known brands in the world – like GT’s Kombucha, True Citrus, and Honey Stinger — and helping them break into new markets. Grovara’s expansion into other complementary verticals will include 10 new product categories over the next 12 months, including beauty, pets, home goods, and alcohol.

Grovara’s CPG expansion is powered by its partnership with Accelerate360, an omni-commerce sales, media, and distribution company that propels promising brands by supercharging affinity and availability. Accelerate360 recently launched 50 models of premium reader eyeglasses on Grovara with many more categories and brands on the way.

“We are excited to partner with Grovara as they establish new product categories and provide expanded opportunities for entrepreneurs and challenger brands” says Accelerate360’s Sam Roberts, VP of eCommerce – Pure Play & Omni-Channel Retail.

Those CPG brands interested in joining Grovara’s platform can reach out for a demo of its SaaS technology here.

Contact:
J.A. Petrucci
215-203-2227
385927@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/grovaras-safe-b2b-cpg-global-trading-platform-expands-product-offering-into-eyewear-will-add-10-plus-complementary-verticals-by-end-of-2025-302297505.html

SOURCE Grovara

Continue Reading

Trending